Literature DB >> 19162364

Comparison of outcomes and costs after hip fracture surgery in three hospitals that have different care systems in Japan.

Akiko Kondo1, Brenda K Zierler, Yayoi Isokawa, Hiroshi Hagino, Yayoi Ito.   

Abstract

Hip fracture is a medical and socioeconomic problem among the 65 years and older population in Japan. Length of hospital stay in Japan is much longer than other developed countries, and the Japanese government has tried to reduce length of stay in order to reduce medical expenditures. The objective of this study was to compare outcomes and costs of health care services for patients with hip fracture surgery among three hospitals with different care systems in Japan. Medical records of patients who were 65 years or older, who had hip fracture surgery within the past 2.5 years were reviewed. A questionnaire was sent to patients and/or their family members to ask patients' health outcomes and approximate costs of care after discharge. Initial hospitalization costs, costs of subsequent transitional care hospital, elders' care services and family's salary loss were estimated and compared among the three hospitals after adjusting for patients' characteristics and treatments. The response rate of the questionnaire was 70% (n=149/211). Patients' outcomes (mortality and ambulatory ability) after discharge were comparable. Hospitals that had shorter lengths of stay reduced costs to themselves, but did not reduce overall costs including care after discharge; however, costs were even higher because patients stayed in subsequent hospitals longer and/or used more elders' care services. Reducing the length of stay in the initial acute care hospitals could be just a method of cost-shifting to subsequent care services and is unlikely to bring an overall cost-savings to the Japanese health care system.

Entities:  

Mesh:

Year:  2009        PMID: 19162364     DOI: 10.1016/j.healthpol.2008.12.006

Source DB:  PubMed          Journal:  Health Policy        ISSN: 0168-8510            Impact factor:   2.980


  14 in total

1.  Modified Blumgart Suturing Technique for Remnant Closure After Distal Pancreatectomy: a Propensity Score-Matched Analysis.

Authors:  Tsutomu Fujii; Suguru Yamada; Kenta Murotani; Hiroyuki Sugimoto; Masashi Hattori; Mitsuro Kanda; Hideki Takami; Goro Nakayama; Shuji Nomoto; Michitaka Fujiwara; Akimasa Nakao; Yasuhiro Kodera
Journal:  J Gastrointest Surg       Date:  2016-02       Impact factor: 3.452

2.  Cost-effectiveness of denosumab versus oral alendronate for elderly osteoporotic women in Japan.

Authors:  T Mori; C J Crandall; D A Ganz
Journal:  Osteoporos Int       Date:  2017-02-17       Impact factor: 4.507

3.  Clinical benefits of neoadjuvant chemoradiotherapy for adenocarcinoma of the pancreatic head: an observational study using inverse probability of treatment weighting.

Authors:  Tsutomu Fujii; Sohei Satoi; Suguru Yamada; Kenta Murotani; Hiroaki Yanagimoto; Hideki Takami; Tomohisa Yamamoto; Mitsuro Kanda; So Yamaki; Satoshi Hirooka; Masanori Kon; Yasuhiro Kodera
Journal:  J Gastroenterol       Date:  2016-05-11       Impact factor: 7.527

4.  A model-based cost-effectiveness analysis of osteoporosis screening and treatment strategy for postmenopausal Japanese women.

Authors:  M Yoshimura; K Moriwaki; S Noto; T Takiguchi
Journal:  Osteoporos Int       Date:  2016-10-14       Impact factor: 4.507

5.  Clinical efficacy and cost-effectiveness of lanthanum carbonate as second-line therapy in hemodialysis patients in Japan.

Authors:  Shunsuke Goto; Hirotaka Komaba; Kensuke Moriwaki; Akira Fujimori; Koji Shibuya; Masato Nishioka; Jong-Il Kim; Kunihiko Yoshiya; Jeongsoo Shin; Hirohito Hasegawa; Masatomo Taniguchi; Hideki Fujii; Shinichi Nishi; Isao Kamae; Masafumi Fukagawa
Journal:  Clin J Am Soc Nephrol       Date:  2011-05-05       Impact factor: 8.237

6.  Cost-effectiveness of implementing guidelines for the treatment of glucocorticoid-induced osteoporosis in Japan.

Authors:  K Moriwaki; H Fukuda
Journal:  Osteoporos Int       Date:  2019-01-04       Impact factor: 4.507

7.  Economic evaluation of osteoporosis liaison service for secondary fracture prevention in postmenopausal osteoporosis patients with previous hip fracture in Japan.

Authors:  K Moriwaki; S Noto
Journal:  Osteoporos Int       Date:  2016-10-04       Impact factor: 4.507

8.  Integrated care through disease-oriented clinical care pathways: experience from Japan's regional health planning initiatives.

Authors:  Etsuji Okamoto; Masaki Miyamoto; Kazuhiro Hara; Jun Yoshida; Masaki Muto; Aizan Hirai; Haruyuki Tatsumi; Masaaki Mizuno; Hiroshi Nagata; Daisuke Yamakata; Hiroshi Tanaka
Journal:  Int J Integr Care       Date:  2011-09-23       Impact factor: 5.120

9.  Cost-effectiveness analysis of once-yearly injection of zoledronic acid for the treatment of osteoporosis in Japan.

Authors:  K Moriwaki; M Mouri; H Hagino
Journal:  Osteoporos Int       Date:  2017-03-06       Impact factor: 4.507

10.  Inverse Probability of Treatment Weighting Analysis of Upfront Surgery Versus Neoadjuvant Chemoradiotherapy Followed by Surgery for Pancreatic Adenocarcinoma with Arterial Abutment.

Authors:  Tsutomu Fujii; Suguru Yamada; Kenta Murotani; Mitsuro Kanda; Hiroyuki Sugimoto; Akimasa Nakao; Yasuhiro Kodera
Journal:  Medicine (Baltimore)       Date:  2015-09       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.